Acidosis and the role of nanotechnology in mitigating cancer progression
Abstract
Far from being a mere epiphenomenon, acidosis is a pivotal factor in the somatic evolution of cancer and its progression toward malignancy. This review provides an inclusive overview of the mechanisms by which acidosis induces and selects for malignant phenotypes. We analyze enhanced invasion and metastasis, chemoresistance, immune surveillance suppression, and metabolic reprogramming. We also briefly examine the clinical development of small-molecule and antibody-based therapies targeting pH regulation. Furthermore, this review outlines various drug delivery and therapeutic systems that respond to extracellular and/or intracellular tumor pH, highlighting the advantages of nanomaterials in precision cancer therapy. With advances in artificial intelligence, nanotechnology is poised to expedite the screening of pH-responsive systems for preclinical research, promoting the development of personalized therapies and the mitigation of adverse reactions.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.